• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET Back to Search Results
Model Number 10220
Device Problems Improper Flow or Infusion (2954); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemolysis (1886); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/06/2021
Event Type  malfunction  
Manufacturer Narrative
Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer reported that they had several 'cells were detected in plasma line from centrifuge' alarms at the beginning of a red blood cell exchange (rbcx) procedure using a spectra optia device.The operator noticed the replacement fluid wasn't going in and reported that the interface was all red.The customer told terumo bct customer support that the hematocrit entered was 26.3% and it was from yesterday.Tbct customer support had the customer increase the hematocrit to 29%.The customer retried the procedure and got the same alarms.A photo was sent to tbct customer support of the interface and it was seen that it was plasma, not red cells.Tbct customer support had the operator pause the procedure and notify the physician.The customer started a saline drip.The customer confirmed the fluids hanging were appropriate.The physician was not available by phone within 3-5 minutes and the operator felt uncomfortable waiting, the patient was disconnected from the device to allow them to figure out what the issue was with the patient's blood.The patient was in fair condition following the procedure.The patient complained of weakness and pain prior to start of procedure.The customer declined to provide patient identifier.The disposable set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
This report is being filed to provide additional information in b.5.Investigation is in process.A follow up report will be provided.
 
Event Description
Hemolysis testing was not performed.The patient had another procedure the next day without complications.The physicians did not respond with any feedback.
 
Manufacturer Narrative
Investigation: photographs of the interface through the viewport and the cassette were provided to tbct clinical support which confirmed the plasma in the connector was red and there was hemolysis.No obvious misassemblies, kinks, or "occlusion" can be observed in the provided images.A review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.The run data file (rdf) confirmed that the first 'cells were detected in plasma line from centrifuge' alarm occurred at 4.8 minutes.There was a total of 10 cells detected alarms during the procedure.There were no inlet pressure low, centrifuge pressure high or level sensor alarms that are consistent with occlusions, clotting that would have resulted in fluid diversion.This suggests that the hemolysis was likely related to the patient's underlying disease.The patient's tbv was 4800 so a custom prime was not performed.This was ruled out as a possible source of hemolysis.Root cause: a definitive root cause for the discolored plasma could not be determined.Possible causes include but are not limited to: the patient's underlying disease state.A misload of the disposable set; occlusion in the disposable set tubing; partial flash, bad seam weld, and/or assembly error on the channel connector.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA EXCHANGE SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
scot hilden
10810 w. collins ave
lakewood, CO 80215
3032314970
MDR Report Key11237493
MDR Text Key259340170
Report Number1722028-2021-00048
Device Sequence Number1
Product Code LKN
UDI-Device Identifier05020583102200
UDI-Public05020583102200
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K183081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 01/27/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/01/2022
Device Model Number10220
Device Catalogue Number10220
Device Lot Number2010163230
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 01/06/2021
Initial Date FDA Received01/27/2021
Supplement Dates Manufacturer Received03/19/2021
08/01/2022
Supplement Dates FDA Received04/06/2021
08/02/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/14/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age00029 YR
Patient SexMale
Patient Weight81 KG
-
-